Moreover, Mtss1 downregulation may be an indicator or involved in the pathogenesis of unfavorable AML subtypes, as MTSS1 expression was low in FLT3-ITD but high in AML1-ETO associated AML. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.